Please ensure Javascript is enabled for purposes of website accessibility

Why Allscripts Healthcare Solutions Stock Is Rising Today

By Brian Feroldi - Aug 3, 2018 at 11:54AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares popped after the company reported second-quarter results. Here's what investors need to know.

What happened

Shares of Allscripts Healthcare Solutions (MDRX -0.24%), an information technology company focused on the healthcare industry, are up 11% as of 11:30 a.m. EDT. The double-digit gain is attributable to its release of mostly positive second-quarter results. 

So what

Here's a review of the key takeaways from the quarter: 

  • Non-GAAP revenue increased 25% to $536 million. That was shy of the $538.2 million in revenue what Wall Street had projected.
  • Non-GAAP earnings per share grew 20% to $0.18. That figured matched market watchers' projection.
  • Contract revenue backlog increased 16% to $4.8 billion. 
  • Non-GAAP gross margin fell by 100 basis points to 47%. 
  • Stock buybacks totaled $44 million in the quarter. The company's board authorized a brand new $250 million buyback program.
Doctor using laptop

Image source: Getty Images.

Mangement also reaffirmed its financial outlook for the year:

  • Non-GAAP revenue is expected to climb at least 17% to a range of $2.15 billion to $2.25 billion.
  • Adjusted EBITDA is expected to grow at least 12% to a range of $420 million to $460 million.
  • Non-GAAP EPS is expected to increase at least 16% to a range of $0.72 to $0.82.

These figures line up well with Wall Street's estimate of $2.18 billion in total revenue and $0.77 in EPS.

Investors are bidding up the stock price in response to the generally positive results.

Now what

Allscripts Healthcare Solutions has badly underperformed the market over the last several years, so today's pop should come as welcome relief to its shareholders.

SPY Chart

SPY data by YCharts.

Looking ahead, Wall Street projects that the company's profits will grow in excess of 18% annually over the next five years. If that number proves to be anywhere close to reality, then the stock's current valuation of about 16 times next year's earnings estimates could prove to be attractive. However, given the company's poor track record of creating shareholder value, I thinks that approaching this stock with a wait-and-see mind-set makes the most sense. Investors who are interested in the healthcare information service stocks might want to consider looking elsewhere.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Allscripts Healthcare Solutions, Inc. Stock Quote
Allscripts Healthcare Solutions, Inc.
$16.73 (-0.24%) $0.04

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/23/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.